Ginger L. Graham
She is the former President and Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, focused on diabetes and obesity (acquired by Bristol-Myers Squibb in 2012). During Ginger’s tenure at Amylin, the company launched two first-in-class medicines for people with diabetes, was listed on the Nasdaq 100 and was rated as one of the Top 10 places in the industry for scientists to work.
Prior to her time at Amylin, Ginger was Group Chairman, Office of the President for Guidant Corporation, a major cardiovascular medical device manufacturer based in Indianapolis, IN. During Ginger’s tenure at Guidant, the company launched the world’s leading stent platform, was listed in the Fortune 500, was recognized by Fortune Magazine as one of the Best Companies to Work For in America, and was included in Industry Week Magazine’s 100 Best Managed Companies in the World.
Ginger has received numerous awards and honors including being named as the Emerging Company Executive of the Year by the Global Health Council in 2005, a Finalist in Marketwatch’s CEO of the Year in 2006, and named as the American Diabetes Association’s Woman of Valor award in 2006. She was included in Pharma VOICE’s “100 of the Most Inspiring People” list in 2006 and World Pharmaceuticals magazine named her number 10 on a list of 40 most influential people in the industry in 2007. Ginger was the first woman CEO named to the PhRMA Board and Executive Committee.
Ms. Graham serves on the Boards of Directors for Walgreens Boots Alliance, Genomic Health, Inc., Surefire Medical, Elcelyx Therapeutics, and Clovis Oncology She serves on the Board of Advisors for the Colorado BioFrontiers Institute and the Scientific Advisory Council for the University of Colorado Center for Women’s Health Research . Ginger frequently speaks at Business Schools and has written for Harvard Business Review.
Ms. Graham received a Bachelor of Science in agricultural economics from the University of Arkansas, and holds an MBA, with distinction, from Harvard University.